Your CORTIMENT ® (budesonide MMX ® ) guide This leaflet is for patients who have been prescribed CORTIMENT ® for the treatment of exa cerbations of their mild to moderate ulcerative colitis. Why have I been prescribed CORTIMENT ® ? You have been prescribed CORTIMENT ® as symptoms of your ulcerative colitis (UC) have reappeared, also known as a fla re-up. What are the symptoms of a flare-up? Possible symptoms of a UC flare-up may include: Frequent diarrhoea that m ay contain blood or pus Urgent bowel movements Abdominal cramping and pain What is CORTIMENT ® ? CORTIMENT ® is an oral topical steroid containing the medicinal p roduct budesonide. It should be ta ken in addition to your current UC treatment, to help get your symp toms back under control (also termed remission). Always take your medication as instructed by your doctor. Failing to do so means you may not receive the full therapeutic benefits of the medication. How to take CORTIMENT ® CORTIMENT ® should be taken orally in the morning. It is important that the tablet is not broken and that you do not chew the tablet. WEEKS Your CORTIMENT ® tablet should be swallowed whole with a glass of wa ter and can be taken with or without food. CORTIMENT ® should be taken for up to 8 weeks, but always follow your healthca re professional’s advice before you stop taking CORTIMENT ® . How CORTIMENT ® works: topical rather than systemic steroid CORTIMENT ® is a topical steroid which means the active ing redient is targeted to the site of inflammation. Systemic steroids however, such as prednisolone, are distributed throughout the whole body CORTIMENT ® ’s specially designed outer coating protects the active ingredient until it reaches the lower part of the small in testine where it dissolves The unique MMX ® technology then releases budesonide at a controlled rate throughout the whole colon, thus targeting the site of inflammation to help get your symp toms back under control (also termed remission) ‘I have been prescribed CORTIMENT ® ’ card Carry the ‘I have been prescribed CORTIMENT ® ’ card with you when collecting your prescription and hand it to your pharmacist to ensure that you are dispensed CORTIMENT ® . Please dispense my prescription as: CORTIMENT ® (budesonide MMX ® ) 9 mg prolonged release tablets OD Reporting of side ef fects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes a ny possible side ef fects not listed in the package leaflet. You can also report side effects directly via HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517; Website: www.hpra.ie; Email: medsafety@hpra.ie. By reporting side effects, you can he lp provide more information on the safety of this medicine. This information leaflet is not intended to be a substitute for medical advice. You should consult your doctor for specific advice about your condition. You should also read through the Patient Information Leaflet, which can be found in your CORTIMENT ® medication pack. Date of preparation: March 2022 | Job code: IE-COR-2200010 Cortiment, FERRING and the FERRING Logo are trademarks of Ferri ng B.V. MMX is a registered trademark of Cosmo Technologies Limited Ferring Ireland Ltd. United Drug House Magna Drive, Magna Business Park Citywest Road, Dublin 24.